Point of View
Results of the REVEAL study. Why should we not welcome a new lipid-lowering agent?
Resultados del estudio REVEAL. ¿Por qué no debemos dar la bienvenida a un nuevo agente hipolipemiante?
Luis Masana
Unitat de Medicina Vascular i Metabolisme, Hospital Universitari Sant Joan, Universitat Rovira I Virgili, IISPV, CIBERDEM, Reus, Tarragona, Spain
Read
959
Timeswas read the article
387
Total PDF
572
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 12 | 21 | 12 | 33 |
| 2025 11 | 65 | 91 | 156 |
| 2025 10 | 39 | 30 | 69 |
| 2025 9 | 29 | 25 | 54 |
| 2025 8 | 22 | 16 | 38 |
| 2025 7 | 32 | 15 | 47 |
| 2025 6 | 13 | 8 | 21 |
| 2025 5 | 24 | 2 | 26 |
| 2025 4 | 16 | 3 | 19 |
| 2025 3 | 14 | 7 | 21 |
| 2025 2 | 17 | 4 | 21 |
| 2025 1 | 14 | 8 | 22 |
| 2024 12 | 11 | 7 | 18 |
| 2024 11 | 26 | 7 | 33 |
| 2024 10 | 8 | 7 | 15 |
| 2024 9 | 6 | 16 | 22 |
| 2024 8 | 6 | 11 | 17 |
| 2024 7 | 9 | 7 | 16 |
| 2024 6 | 9 | 7 | 16 |
| 2024 5 | 6 | 4 | 10 |
| 2024 4 | 7 | 8 | 15 |
| 2024 3 | 10 | 2 | 12 |
| 2024 2 | 11 | 6 | 17 |
| 2024 1 | 9 | 1 | 10 |
| 2023 12 | 6 | 9 | 15 |
| 2023 11 | 8 | 10 | 18 |
| 2023 10 | 12 | 5 | 17 |
| 2023 9 | 9 | 2 | 11 |
| 2023 8 | 6 | 1 | 7 |
| 2023 7 | 2 | 1 | 3 |
| 2023 6 | 4 | 5 | 9 |
| 2023 5 | 8 | 1 | 9 |
| 2023 4 | 1 | 0 | 1 |
| 2023 3 | 4 | 3 | 7 |
| 2023 2 | 4 | 0 | 4 |
| 2023 1 | 8 | 1 | 9 |
| 2022 12 | 10 | 2 | 12 |
| 2022 11 | 5 | 6 | 11 |
| 2022 10 | 6 | 5 | 11 |
| 2022 9 | 4 | 4 | 8 |
| 2022 8 | 9 | 6 | 15 |
| 2022 7 | 7 | 4 | 11 |
| 2022 6 | 8 | 3 | 11 |
| 2022 5 | 6 | 3 | 9 |
| 2022 4 | 8 | 5 | 13 |
| 2022 3 | 5 | 5 | 10 |
| 2022 2 | 8 | 2 | 10 |
Show all